Tipharco Pharmaceutical Joint Stock Co
HHNX:DTG12,300.00
VND
-500.00
(-3.91%)
Tipharco Pharmaceutical Joint Stock Co
HNX:DTG
(Hanoi Stock Exchange)
Recent
price
12,300.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Tipharco Pharmaceutical Joint Stock Company is a Vietnam-based pharmaceutical manufacturing and healthcare enterprise primarily engaged in the research, development, production, marketing, and distribution of modern pharmaceuticals, traditional herbal medicines, dietary supplements, and medical supplies. The company offers a comprehensive product portfolio categorized by therapeutic applications, including antibiotics, antibacterial, and antifungal medications; analgesic, antipyretic, and anti-inflammatory formulations; cardiovascular and metabolic disorder treatments; respiratory, antitussive, and antihistamine remedies; gastrointestinal and hepatobiliary agents; vitamins, mineral complexes, and nutritional health supplements; herbal medicinal products; topical dermatological ointments and creams; and antiseptic solutions, diagnostic supplies, and medical consumables. Tipharco operates modern manufacturing facilities compliant with World Health Organization Good Manufacturing Practice (WHO-GMP), Good Laboratory Practice (WHO-GLP), and Good Storage Practice (WHO-GSP) standards, producing various dosage forms such as tablets, film-coated tablets, hard capsules, oral suspensions, dry powders, granules, and liquid syrups. The company supplies public and private hospitals, clinics, retail pharmacies, and wholesale distributors across all regions of Vietnam, while engaging in selective international export activities. Founded in 1976 and headquartered in My Tho City, Tien Giang Province, Vietnam, the entity was formerly known as Tien Giang Pharmaceutical and Medical Equipment Joint Stock Company. In recent major developments, Tipharco underwent strategic ownership and corporate restructuring following its integration into the Bamboo Capital Group corporate ecosystem; successfully transitioned and listed its shares on the Hanoi Stock Exchange under the ticker symbol DTG; executed equity capital increases to fund manufacturing expansion; advanced upgrade initiatives across its production facilities toward European Union Good Manufacturing Practice (EU-GMP) certification; and forged strategic commercial partnerships to accelerate national over-the-counter retail market penetration and contract manufacturing operations.